Qyuns Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
353
- Stock Symbol
-
02509
- Share Price
-
$1.87
- (As of Friday Closing)
Qyuns General Information
Description
Qyuns Therapeutics Co Ltd is a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline. It has built a pipeline that covers the four disease areas in the field, including skin, rheumatic, respiratory, and digestive diseases. The group is principally engaged in the research and development, manufacturing, and commercialisation of biologic therapies for autoimmune and allergic diseases. Key revenue is generated from the PRC.
Contact Information
Website
www.qyuns.netCorporate Office
- Room 1310, Building 1
- Number 907 Yaocheng Avenue
- Taizhou, Jiangsu 225300
- China
Corporate Office
- Room 1310, Building 1
- Number 907 Yaocheng Avenue
- Taizhou, Jiangsu 225300
- China
Qyuns Stock Performance
As of 13-Nov-2026, Qyuns’s stock price is $1.87. Its current market cap is $419M with 223M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.87 | $1.90 | $1.69 - $3.14 | $419M | 223M | 114K | $0.35 |
Qyuns Financials Summary
As of 30-Jun-2026, Qyuns has a trailing 12-month revenue of $146M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 336,341 | 563,395 | 189,789 | |
| Revenue | 146,417 | 112,213 | 22,130 | 0 |
| EBITDA | 77,388 | 48,695 | (42,016) | (67,378) |
| Net Income | 78,043 | 43,726 | (46,767) | (71,768) |
| Total Assets | 281,258 | 228,726 | 134,776 | 112,234 |
| Total Debt | 101,041 | 82,897 | 72,272 | 48,819 |
Qyuns Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Qyuns Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Qyuns Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Qyuns Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Qyuns ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Qyuns FAQs
-
When was Qyuns founded?
Qyuns was founded in 2015.
-
Where is Qyuns headquartered?
Qyuns is headquartered in Taizhou, China.
-
What is the size of Qyuns?
Qyuns has 353 total employees.
-
What industry is Qyuns in?
Qyuns’s primary industry is Drug Discovery.
-
Is Qyuns a private or public company?
Qyuns is a Public company.
-
What is Qyuns’s stock symbol?
The ticker symbol for Qyuns is 02509.
-
What is the current stock price of Qyuns?
As of 13-Nov-2026 the stock price of Qyuns is $1.87.
-
What is the current market cap of Qyuns?
The current market capitalization of Qyuns is $419M.
-
What is Qyuns’s current revenue?
The trailing twelve month revenue for Qyuns is $146M.
-
What is Qyuns’s annual earnings per share (EPS)?
Qyuns’s EPS for 12 months was $0.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
